Literature DB >> 6538346

Effects of hypoxia and acidosis on vascular plasminogen activator release in the pig ear perfusion system.

L Tappy, J Hauert, F Bachmann.   

Abstract

The influence of hypoxia and acidosis on the release of vascular plasminogen activator was studied in the isolated perfused pig ear. Perfusion with deoxygenated or acid solutions led to significant increases in plasminogen activator release (p less than 0.001); acid solutions of pH 6.7 were more effective than those of pH 6.9. Perfusions with lactate and AMP, two metabolic products which might act as mediators of fibrinolytic stimulation during hypoxia, resulted in moderate increases of plasminogen activator in the effluent (p less than 0.01).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6538346     DOI: 10.1016/0049-3848(84)90172-5

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  4 in total

1.  Centrifugal and roller pumps--are there differences in coagulation and fibrinolysis during and after cardiopulmonary bypass?

Authors:  B E Steinbrueckner; U Steigerwald; F Keller; K Neukam; O Elert; J Babin-Ebell
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

2.  Changes in coagulation and fibrinolytic parameters caused by extracorporeal circulation.

Authors:  R Grossmann; J Babin-Ebell; M Misoph; S Schwender; K Neukam; T Hickethier; O Elert; F Keller
Journal:  Heart Vessels       Date:  1996       Impact factor: 2.037

3.  Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.

Authors:  D J Pinsky; H Liao; C A Lawson; S F Yan; J Chen; P Carmeliet; D J Loskutoff; D M Stern
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

4.  Impaired fibrinolysis in the hemolytic-uremic syndrome of childhood.

Authors:  D Menzel; M Levi; G Dooijewaard; M Peters; J W ten Cate
Journal:  Ann Hematol       Date:  1994-01       Impact factor: 3.673

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.